ARCHIVES

FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities (8-page issue).

April 25, 2003

Cullen Credits Staff With Success Of STCP, Strong Prevention Program a NCI

May 19, 1989

Community Based Control Program Taking Final Shape

April 29, 1977

Sanding Study Section For Cancer Control Grants Needed, Board Says

May 17, 1985

NLST Suggests 18.5 Percent Of LDCT-Detected Cancers Could Be Indolent

December 27, 2013

Leukemia Society Seeks Applicants for Grants

December 9, 1994